Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Abbott

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Abbott

Regulatory records
4
Linked recall entries
1
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 4 FDA records to the applicant name Abbott. It includes 1 original PMA approval. 3 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Dec 6, 2019 to Oct 30, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code DSQ appears in 4 of the 4 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P170038, with 4 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 3 linked filings have a current plain-language explanation checked against the recorded FDA decision.

Applicant mailing address recorded by FDA: 6035 Stoneridge Dr., Pleasanton, CA, 94588. Recorded on P170038/S034, decision dated Oct 30, 2026.

Changes described in PMA records

P170038/S034: CentriMag Circulatory Support System

FDA posted a 30-day notice for supplement S034 to PMA P170038 for the CentriMag Circulatory Support System. The stated decision scope is a manufacturing process change to the routine bioburden monitoring program for the CentriMag Blood Pump. The supplement type is listed as Process Change - Manufacturer/Sterilizer/Packager/Supplier, and the decision is recorded as OK30.

This notice does not represent a new approval of the entire system or a change in indication. The source statement identifies only the bioburden monitoring program change; it does not describe the specific monitoring method, acceptance criteria, or manufacturing site affected. No safety or effectiveness conclusion is provided in the source fields.

FDA approval-order wording

a manufacturing process change to the routine bioburden monitoring program for the CentriMag Blood Pump

Oct 30, 2026 · 30-Day Notice

P170038/S033: CentriMag Circulatory Support System

The FDA database entry P170038/S033 records a 30-day notice for Abbott's CentriMag Circulatory Support System, classified under product code DSQ for ventricular assist bypass in cardiovascular devices. The reported change is the addition of "an additional second-tier supplier of the CentriMag Motor Protection Cup component," with the supplement reason labeled as a process change covering manufacturer, sterilizer, packager, or supplier. This describes a supply-chain arrangement for one named component, not a modification to the device's approved design or labeling.

Because S033 is a supplement to PMA P170038, it sits within that original approval rather than constituting a new approval of the CentriMag system as a whole. The source statement gives the component and the supplier tier but does not name the supplier, describe qualification testing, or present data bearing on safety or clinical effectiveness; the notice's purpose is regulatory reporting of the change, and should not be read as independent confirmation of either.

FDA approval-order wording

an additional second-tier supplier of the CentriMag Motor Protection Cup component

Oct 2, 2026 · 30-Day Notice

P170038/S032: CentriMag Circulatory Support System

The FDA record for P170038/S032 describes a 30-day notice under the CentriMag Circulatory Support System PMA, with the stated purpose of replacing existing wave soldering equipment with new wave soldering equipment. The listed supplement reason is a process change involving a manufacturer, sterilizer, packager, or supplier. The device category is ventricular (assist) bypass, specialty cardiovascular, product code DSQ, applicant Abbott.

The identifier establishes this as a supplement to PMA P170038 rather than a new approval of the whole system, and it is a manufacturing notice rather than an original PMA. The statement does not name the affected facility, equipment model, process controls, or validation data, and it does not say whether soldering affects a patient-contacting component. The reported purpose is not evidence of safety or clinical effectiveness, and the record gives no basis for a new indication or clinical use.

FDA approval-order wording

replacement of the existing wave soldering equipment with new wave soldering equipment

Sep 2, 2026 · 30-Day Notice

P170038: CentriMag Circulatory Support System

FDA’s recorded scope: Approval for temporary circulatory support for up to 30 days for one or both sides of the heart to treat postcardiotomy patients who fail to wean from cardiopulmonary bypass, providing a bridge to decision when it is unclear whether the patient's heart will recover or whether the patient will need alternative, longer-term therapy.

Dec 6, 2019

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

RECALL COVERAGE

Recalls linked to this firm

MedtechLedger links 1 FDA enforcement entry through the recorded recalling firm or an exact submission number published in FDA’s recall data. 1 Class II records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.

Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.

Source information

Source updated Nov 11, 2026. Retrieved Nov 19, 2026.

Devices & associated records

Product / regulatory recordCompanyPathwayDecision dateSource
AbbottPMA supplementOct 30, 2026FDA
AbbottPMA supplementOct 2, 2026FDA
AbbottPMA supplementSep 2, 2026FDA
AbbottPMA approvalDec 6, 2019FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 19, 2026.